Benjamin F. Edwards & Company’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GF
FLAM
Benjamin F. Edwards & Company's NEO Position: Q2 2024 in Review
Benjamin F. Edwards & Company increased its NeoGenomics (NEO) stake by 85% in Q2 2024, buying an estimated $2.68K and bringing the position to 411 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1882.
Benjamin F. Edwards & Company first reported a position in NEO in Q2 2019 and has held it in 21 quarters since. The position peaked at $162K in Q4 2020. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.
- Benjamin F. Edwards & Company held 411 shares of NeoGenomics worth $5K as of Q2 2024.
- Benjamin F. Edwards & Company bought 189 NeoGenomics shares in Q2 2024, an estimated $2.68K.
- NeoGenomics made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1882 holding.
- Benjamin F. Edwards & Company first reported a position in NeoGenomics in Q2 2019 and has held it in 21 quarters since.
- Benjamin F. Edwards & Company's NeoGenomics position peaked at $162K in Q4 2020.
- 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.